Impact of the Ketogenic Diet on Neurological Diseases: A Review
Background: The ketogenic diet (KD), high in fat and low in carbohydrates, was introduced in the 1920s as a non-pharmacological treatment for refractory epilepsy. Although its mechanism of action is not fully understood, beneficial effects have been observed in neurological diseases such as epilepsy...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/15/1/71 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832588140057985024 |
---|---|
author | Carmen Rubio Alejandro López-Landa Hector Romo-Parra Moisés Rubio-Osornio |
author_facet | Carmen Rubio Alejandro López-Landa Hector Romo-Parra Moisés Rubio-Osornio |
author_sort | Carmen Rubio |
collection | DOAJ |
description | Background: The ketogenic diet (KD), high in fat and low in carbohydrates, was introduced in the 1920s as a non-pharmacological treatment for refractory epilepsy. Although its mechanism of action is not fully understood, beneficial effects have been observed in neurological diseases such as epilepsy, Alzheimer’s disease, and Parkinson’s disease. Objective: This review examines the impact of the ketogenic diet and its molecular and neuroglial effects as a complementary therapy for neurological diseases. Discussion: KD is associated with neuroprotective and antioxidant effects that improve mitochondrial function, regulate neurotransmitter flow, and reduce neuroinflammation and oxidative stress. Glial cells play an essential role in the utilization of ketone bodies (KBs) within the central nervous system’s metabolism, particularly during ketosis induced by the KD. Thus, the KD represents a broad and promising strategy that involves both neurons and glial cells, with a molecular impact on brain metabolism and neuroinflammatory homeostasis. Conclusion: Multiple molecular mechanisms have been identified to explain the benefits of the KD in neurological diseases; however, further experimental and clinical studies are needed to address various molecular pathways in order to achieve conclusive results. |
format | Article |
id | doaj-art-7990e29ba5084ae0ac9e5cb3117913fd |
institution | Kabale University |
issn | 2075-1729 |
language | English |
publishDate | 2025-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Life |
spelling | doaj-art-7990e29ba5084ae0ac9e5cb3117913fd2025-01-24T13:38:40ZengMDPI AGLife2075-17292025-01-011517110.3390/life15010071Impact of the Ketogenic Diet on Neurological Diseases: A ReviewCarmen Rubio0Alejandro López-Landa1Hector Romo-Parra2Moisés Rubio-Osornio3Neurophysiology Department, Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez”, Mexico City 14269, MexicoNeurophysiology Department, Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez”, Mexico City 14269, MexicoNeurophysiology Department, Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez”, Mexico City 14269, MexicoNeurochemistry Department, Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez”, Mexico City 14269, MexicoBackground: The ketogenic diet (KD), high in fat and low in carbohydrates, was introduced in the 1920s as a non-pharmacological treatment for refractory epilepsy. Although its mechanism of action is not fully understood, beneficial effects have been observed in neurological diseases such as epilepsy, Alzheimer’s disease, and Parkinson’s disease. Objective: This review examines the impact of the ketogenic diet and its molecular and neuroglial effects as a complementary therapy for neurological diseases. Discussion: KD is associated with neuroprotective and antioxidant effects that improve mitochondrial function, regulate neurotransmitter flow, and reduce neuroinflammation and oxidative stress. Glial cells play an essential role in the utilization of ketone bodies (KBs) within the central nervous system’s metabolism, particularly during ketosis induced by the KD. Thus, the KD represents a broad and promising strategy that involves both neurons and glial cells, with a molecular impact on brain metabolism and neuroinflammatory homeostasis. Conclusion: Multiple molecular mechanisms have been identified to explain the benefits of the KD in neurological diseases; however, further experimental and clinical studies are needed to address various molecular pathways in order to achieve conclusive results.https://www.mdpi.com/2075-1729/15/1/71ketogenic dietneurological diseasesneuroglianeuroinflammation |
spellingShingle | Carmen Rubio Alejandro López-Landa Hector Romo-Parra Moisés Rubio-Osornio Impact of the Ketogenic Diet on Neurological Diseases: A Review Life ketogenic diet neurological diseases neuroglia neuroinflammation |
title | Impact of the Ketogenic Diet on Neurological Diseases: A Review |
title_full | Impact of the Ketogenic Diet on Neurological Diseases: A Review |
title_fullStr | Impact of the Ketogenic Diet on Neurological Diseases: A Review |
title_full_unstemmed | Impact of the Ketogenic Diet on Neurological Diseases: A Review |
title_short | Impact of the Ketogenic Diet on Neurological Diseases: A Review |
title_sort | impact of the ketogenic diet on neurological diseases a review |
topic | ketogenic diet neurological diseases neuroglia neuroinflammation |
url | https://www.mdpi.com/2075-1729/15/1/71 |
work_keys_str_mv | AT carmenrubio impactoftheketogenicdietonneurologicaldiseasesareview AT alejandrolopezlanda impactoftheketogenicdietonneurologicaldiseasesareview AT hectorromoparra impactoftheketogenicdietonneurologicaldiseasesareview AT moisesrubioosornio impactoftheketogenicdietonneurologicaldiseasesareview |